Cite

HARVARD Citation

    Baljevic, M. et al. (2022). Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment. EJHaem. 3 (4), pp. 1270-1276. [Online]. 
  
Back to record